Integrative Biomedical Research
Programmable DNA binding oligomers for control of transpcription in angiogenesis
Sarah Furkan
Journal of Angiotherapy 1 (1) 033-035 https://doi.org/10.25163/angiotherapy.11000721108100517
Submitted: 11 September 2016 Revised: 16 February 2017 Published: 10 May 2017
Abstract
The drug discovery opportunities with chemistry, biology and human medicine are increasing by mapping and sequencing the genetic blueprint of humans, mice and other organisms. The realization of the function of 25,000 genes of humans and understanding the biological circles that control these genes will be a crucial starting point for new chemistry technologies. The cellular events that lead to cancer and diseases in human involve aberrant gene expression. Small molecules that can be programmed to mimic transcription factors could be useful tools in biology and potentially in human medicine as they could bind a large repertoire of DNA sequences in the human genome.
Keywords: Transcription, Oligomers, DNA, Chromatin, Drug Discovery, Angiogenesis
References
Recommended articles
Nanotheranostics for Overcoming Tumor Heterogeneity and Drug Resistance in Solid Tumors: Imaging-Guided Therapy, Clinical Progress, and Future Directions
Bacterial Cellulose Nanocomposite Dressings Loaded with Antimicrobial Nanoparticles for Diabetic Foot Ulcers: Fabrication, Mechanisms, and Preclinical Evidence
CRISPR-Cas13 Paper Biosensors for Point-of-Care Genotyping of Thalassemia Mutations: Mechanisms, Isothermal Coupling, and Translational Readiness
Save
Citation
View
Share